Indivior
News/ News/ News/ Patients/ Sales and Marketing
After final $600M opioid settlement, Indivior looks to the future
Phil Taylor
addiction, Indivior, litigation, opioid, opioid crisis, US
0 Comment
News/ News/ News/ Patients/ Sales and Marketing/ Top stories
Indivior ex-CEO could face jail time after opioid conviction
Phil Taylor
Indivior, litigation, senior management, US
0 Comment
FDA to reconsider Braeburn’s opioid addiction drug after court ruling
Richard Staines
addiction, Braeburn, Indivior, opioids
0 Comment
Indivior stung by fraud charges over US marketing
Phil Taylor
Indivior, opioid addiction, Suboxone Film
0 Comment
Debates & Insight/ Insights/ Sales and Marketing/ Slider in whitepapers
Ensuring delivery of healthcare professional education
louise.bellamy@pharmaphorum.com
content management system, Indivior, Veeva Commercial Cloud
0 Comment
News/ R&D/ Sales and Marketing
Indivior’s once-monthly schizophrenia injection gets US green light
Joy Persaud
fda, FDA approval, Indivior, Perseris, schizophrenia
0 Comment